ReviewCytokines as mediators of depression: What can we learn from animal studies?
Introduction
In recent years, it has been postulated that depression may be caused by cytokine secretion associated with activation of the immune system. This hypothesis was proposed initially because the incidence of immune abnormalities is higher in depressed patients than in the general population, and because depression is a common side effect of cytokine therapy. The hypothesis gained momentum when it was shown that immune activation and administration to animals of endotoxin (lipopolysaccharide, LPS) or the cytokine, interleukin-1 (IL-1), could induce a behavioral pattern resembling that commonly observed in sick animals, including man. This behavioral pattern has become known as sickness behavior. There are many similarities between sickness behavior and the symptoms of depression. Thus it was suggested that cytokines could induce depression, or indeed were the cause of depression. The hypothesis has come to be called the cytokine hypothesis of depression, although proponents differ on whether cytokines are a cause of major depressive disorder, or the cause.
The cytokine hypothesis of depression posits that depression is caused by the actions of cytokines. Cytokines are proteins and glycoproteins secreted by immune cells that function as signals among and between immune cells. They are the hormones of the immune system. It is now known that cytokines have effects on cells outside the immune system, and that non-immune cells can synthesize and secrete cytokines. Thus cytokines can be regarded as classical hormones that can function locally or systemically to orchestrate immune responses, and can also coordinate immune responses with those of other physiological systems in the body, including the nervous system.
The cytokine hypothesis of depression derives from both clinical and experimental observations. The clinical observations were made on patients treated with interferons (IFN's) and interleukin-2 (IL-2). Such patients often displayed influenza-like symptoms and nonspecific neuropsychiatric symptoms, some of which are characteristics of depression. However, the initial interest was not focused on depression, although depression is a relatively common side-effect. Immune abnormalities in depressed patients have been widely reported for more than 30 years. The earliest studies suggested deficient immune function in depressed patients, but the results were inconsistent and highly variable (see Weisse, 1992). Subsequent studies indicated that depressed patients often exhibited immune activation, and that depression was more frequent in patients with diseases having an immunological component (Kronfol, 2002). However, the results were quite varied; immune function in depressed patients was decreased in some aspects, but activated in others.
The interest in an immune system involvement in depression intensified around 15 years ago with the juxtaposition of the above observations on immune abnormalities in depressed patients with the effects of immune challenges in animals. In the animal studies, it was shown that administration of LPS or IL-1 induced a behavioral syndrome that became known as ‘sickness behavior’ (Kent et al., 1992). Smith first suggested that depression was associated with increased secretion of cytokines (especially IL-1) by macrophages (Smith, 1991). He noted that administration of IL-1 mimicked not only some of the behavioral characteristics of depression, but also activated the hypothalamo–pituitary–adrenocortical axis (HPAA). This macrophage hypothesis of depression attracted immediate attention, because it was compatible with a number of earlier findings in depressed patients.
Section snippets
Experimental evidence for the cytokine hypothesis of depression
The experimental evidence for the cytokine hypothesis of depression is summarized in Table 1. Each of these points will be reviewed in turn, focusing on the evidence from animal models.
Effects of immune activation and cytokines in classical tests of depression
The cytokine hypothesis of depression would be strengthened if immune stimulation or cytokine administration proved positive in classical models of depression. Generally, these models are based on the assumption that a particular behavioral pattern resembles a human depressive symptom, and/or it is selectively sensitive to clinically effective antidepressant treatments. The most recent reviews indicate that there are some half dozen rodent models of depression (Cryan et al., 2002, Cryan and
Conclusions
The above review indicates some associations between the appearance of cytokines and major depressive disorder. However, no clear causal relationship has been established. Administration of certain cytokines to humans (especially IFNα and IL-2) induces symptoms of depression in some patients, but such responses occur in only a minority of patients, and many other neuropsychiatric symptoms may also be induced. Immune activation appears more frequently in depressed patients than in the general
Acknowledgements
The authors' research included or referred to in this article was supported by the US National Institutes of Health (MH46261 and NS35370), and by the EU Framework 6 NEWMOOD Integrated Project and the Polish Committee for Scientific Research, (KBN) Grant 3 PO 4C05825. We thank Christina A. Meyers, PhD (University of Texas MD Anderson Cancer Center) for suggestions for improving the manuscript.
References (193)
- et al.
Pain perception threshold in major depression
Biol. Psychiat.
(1993) - et al.
Interleukin-2 decreases accumbal dopamine efflux and responding for rewarding lateral hypothalamic stimulation
Brain Res.
(1996) - et al.
Differential effects of interleukin (IL)-1β, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation
Brain Res.
(1998) - et al.
Differential effects of lipopolysaccharide on food hoarding behavior and food consumption in rats
Brain Behav. Immun.
(1997) - et al.
Differential effects of lipopolysaccharide on pup retrieving and nest building in lactating mice
Brain Behav. Immun.
(1997) - et al.
Effects of chronic mild stress on serum complement activity, saccharin preference, and corticosterone levels in Flinders lines of rats
Physiol. Behav.
(1995) - et al.
Effects of chronic mild stress (CMS) and imipramine administration, on spleen mononuclear cell proliferative response, serum corticosterone level and brain norepinephrine content in male mice
Psychoneuroendocrinology
(1999) - et al.
The effects of chronic mild stress on male Sprague–Dawley and Long Evans rats: I. Biochemical and physiological analyses
Behav. Brain Res.
(2002) - et al.
The effects of endogenous interleukin-1 bioactivity on locus coeruleus neurons in response to bacterial and viral substances
Brain Res.
(2004) - et al.
Neurobehavioral effects of interferon-α in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions
Neuropsychopharmacology
(2002)
Chronic treatment with the antidepressant tianeptine attenuates lipopolysaccharide-induced Fos expression in the rat paraventricular nucleus and HPA axis activation
Psychoneuroendocrinology
The malaise theory of depression: major depressive disorder is sickness behavior and antidepressants are analgesic
Med. Hypotheses
Changes in sleep architecture following chronic mild stress
Biol. Psychiatr.
Assessing antidepressant activity in rodents: recent developments and future needs
Trends Pharmacol. Sci.
Exposure to forced swim stress does not alter central production of IL-1
Brain Res.
The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-α induced alterations to monoamine turnover in prefrontal cortex and hippocampus
Brain Res.
Interleukin-1 affects the behavioral despair response in rats by an indirect mechanism which requires endogenous CRF
Brain Res.
Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action
Biol. Psychiatr.
Evolutionary psychiatry. Adaptationist and nonadaptationist conceptualizations
Prog. Neuropsychopharmacol. Biol. Psychiatry
Urinary excretion of biopterin and neopterin in psychiatric disorders
Psychiatr. Res.
Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone
Life Sci.
The role of interleukin-1 and tumor necrosis factor α in the neurochemical and neuroendocrine responses to endotoxin
Brain Res. Bull.
The role of cyclo-oxygenase and lipoxygenase in the interleukin-1-induced activation of the HPA axis: dependence on the route of injection
Life Sci.
Behavioral responses to stress are intact in CRF-deficient mice
Brain Res.
The role of cyclooxygenases in endotoxin- and interleukin-1-induced hypophagia
Brain Behav. Immun.
Interleukin-1β induced corticosterone elevation and hypothalamic NE depletion is vagally mediated
Brain Res. Bull.
Chronic mild stress and sucrose consumption: validity as a model of depression
Physiol. Behav.
Effect of chronic mild stress on circadian rhythms in the locomotor activity in rats
Pharmacol. Biochem. Behav.
Neuroendocrine measures and lymphocyte subsets in depressive illness: influence of a clinical interview concerning life experiences
Psychoneuroendocrinology
Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis
J. Psychiatr. Res.
Brain Interleukin-1 receptors: mapping, characterization and modulation
Biological basis of the behavior of sick animals
Neurosci. Biobehav. Rev.
Self-stimulation from the mesencephalon following intraventricular interleukin-2 administration
Brain Res. Bull.
Acute adrenocortical stimulation by recombinant gamma interferon in human controls
Life Sci.
IL-1β immunoreactive neurons in the human hypothalamus: Reduced numbers in multiple sclerosis
J. Neuroimmunol.
Interleukin-1 induces changes in norepinephrine metabolism in the rat brain
Brain Behav. Immun.
Effect of single intracerebroventricular injection of α-interferon on monoamine concentrations in the rat brain
Eur. Neuropsychopharmacol.
The olfactory bulbectomized rat as a model of depression: an update
Pharmacol. Therap.
Sickness behavior as a new target for drug development
Trends Pharmacol. Sci.
Reduction in food and water intake induced by microinjection of interleukin-1β in the ventromedial hypothalamus of the rat
Physiol. Behav.
The effect of mild chronic stress, as a model of depression, on the immunoreactivity of C57BL/6J mice
Int. J. Immunopharmacol.
Effect of interferon-alpha on tyrosine hydroxylase and catecholamine levels in the brain of rats
Life Sci.
Unaltered monocyte function in patients with major depression before and after three months of antidepressive therapy
Biol. Psychiatr.
Behavioral effects of cytokines
Brain Behav. Immun.
Effects of interleukin-1β on food-maintained behavior in the mouse
Brain Behav. Immun.
Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice
Mol. Brain Res.
Immunoreactive interleukin-1B localization in the rat forebrain
Brain Res.
Mouse tumor necrosis factor-α increases brain tryptophan concentrations and norepinephrine metabolism while activating the HPA axis in mice
Neuroimmunomodulation
Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features
Mol. Psychiatr.
Gender differences in the behavioral response to interleukin-1: neurochemical mechanisms
Neuroimmunomodulation
Cited by (383)
Bidirectional associations between dietary diversity and depressive symptoms in Chinese adult women: A retrospective cohort study
2024, Journal of Affective DisordersGynura procumbens and selected metabolites: Amelioration of depressive-like behaviors in mice and risperidone-induced hyperprolactinemia in rats
2024, Biomedicine and PharmacotherapyRoflumilast: Modulating neuroinflammation and improving motor function and depressive symptoms in multiple sclerosis
2024, Journal of Affective DisordersAssociation between suicidal behavior and impaired glucose metabolism in first-episode drug-naïve patients with schizophrenia
2024, Progress in Neuro-Psychopharmacology and Biological PsychiatryExploring the role of biologics in depression
2022, Cellular Signalling